Cytokinetics Inc (CYTK)
53.93
+1.22
(+2.31%)
USD |
NASDAQ |
Jun 14, 16:00
53.96
+0.03
(+0.06%)
After-Hours: 20:00
Cytokinetics Accounts Receivable (Quarterly): 0.834M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.834M |
December 31, 2023 | 1.283M |
September 30, 2023 | 2.499M |
June 30, 2023 | 0.985M |
March 31, 2023 | 1.006M |
December 31, 2022 | 0.147M |
September 30, 2022 | 2.294M |
June 30, 2022 | 1.973M |
March 31, 2022 | 6.056M |
December 31, 2021 | 51.82M |
September 30, 2021 | 0.644M |
June 30, 2021 | 2.701M |
March 31, 2021 | 4.514M |
December 31, 2020 | 4.42M |
September 30, 2020 | 4.965M |
June 30, 2020 | 2.254M |
March 31, 2020 | 2.704M |
December 31, 2019 | 5.163M |
September 30, 2019 | 6.576M |
June 30, 2019 | 8.993M |
March 31, 2019 | 4.165M |
December 31, 2018 | 2.231M |
September 30, 2018 | 9.156M |
June 30, 2018 | 0.236M |
March 31, 2018 | 0.037M |
Date | Value |
---|---|
December 31, 2017 | 1.112M |
September 30, 2017 | 10.00M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.91M |
December 31, 2016 | 0.024M |
September 30, 2016 | 67.00M |
June 30, 2016 | 0.026M |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.012M |
September 30, 2015 | 0.047M |
June 30, 2015 | 0.004M |
March 31, 2015 | 0.97M |
December 31, 2014 | 46.65M |
September 30, 2014 | 1.191M |
June 30, 2014 | 0.319M |
March 31, 2014 | 2.116M |
December 31, 2013 | 0.005M |
September 30, 2013 | 0.00 |
June 30, 2013 | 16.00M |
March 31, 2013 | 0.328M |
December 31, 2012 | 0.004M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.003M |
March 31, 2012 | 0.083M |
December 31, 2011 | 0.014M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.147M
Minimum
Dec 2022
51.82M
Maximum
Dec 2021
5.592M
Average
2.60M
Median
Accounts Receivable (Quarterly) Benchmarks
Amgen Inc | 6.776B |
Johnson & Johnson | 14.95B |
Eli Lilly and Co | 7.886B |
Madrigal Pharmaceuticals Inc | -- |
Viking Therapeutics Inc | -- |